Arrowhead Pharmaceuticals Inc (ARWR)
25.84
-0.66
(-2.49%)
USD |
NASDAQ |
Jun 14, 16:00
25.87
+0.03
(+0.12%)
Pre-Market: 20:00
Arrowhead Pharmaceuticals Cash and Short Term Investments (Quarterly): 523.11M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 523.11M |
December 31, 2023 | 220.28M |
September 30, 2023 | 403.63M |
June 30, 2023 | 451.70M |
March 31, 2023 | 481.00M |
December 31, 2022 | 494.53M |
September 30, 2022 | 376.40M |
June 30, 2022 | 416.50M |
March 31, 2022 | 401.90M |
December 31, 2021 | 330.13M |
September 30, 2021 | 367.79M |
June 30, 2021 | 516.31M |
March 31, 2021 | 577.32M |
December 31, 2020 | 305.33M |
September 30, 2020 | 315.49M |
June 30, 2020 | 287.03M |
March 31, 2020 | 307.61M |
December 31, 2019 | 502.00M |
September 30, 2019 | 258.70M |
June 30, 2019 | 236.90M |
March 31, 2019 | 218.20M |
December 31, 2018 | 243.75M |
September 30, 2018 | 76.53M |
June 30, 2018 | 60.48M |
March 31, 2018 | 91.54M |
Date | Value |
---|---|
December 31, 2017 | 50.70M |
September 30, 2017 | 65.61M |
June 30, 2017 | 75.14M |
March 31, 2017 | 86.63M |
December 31, 2016 | 102.11M |
September 30, 2016 | 85.37M |
June 30, 2016 | 44.65M |
March 31, 2016 | 61.46M |
December 31, 2015 | 76.60M |
September 30, 2015 | 98.75M |
June 30, 2015 | 110.53M |
March 31, 2015 | 116.01M |
December 31, 2014 | 127.52M |
September 30, 2014 | 154.16M |
June 30, 2014 | 162.18M |
March 31, 2014 | 160.65M |
December 31, 2013 | 75.63M |
September 30, 2013 | 28.14M |
June 30, 2013 | 33.08M |
March 31, 2013 | 3.314M |
December 31, 2012 | 2.987M |
September 30, 2012 | 3.484M |
June 30, 2012 | 2.392M |
March 31, 2012 | 3.674M |
December 31, 2011 | 6.845M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
220.28M
Minimum
Dec 2023
577.32M
Maximum
Mar 2021
388.68M
Average
389.15M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Alnylam Pharmaceuticals Inc | 2.371B |
Viking Therapeutics Inc | 962.98M |
Ionis Pharmaceuticals Inc | 2.206B |
Madrigal Pharmaceuticals Inc | 1.059B |
Intellia Therapeutics Inc | 791.29M |